These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4964297)

  • 1. [Separation of some multicomponent preparations by means of column chromatography. I. Separation of dihydroergotoxine (Hydergine) from p-aminobenzoyl-2-diethylamino-4-methylpentanone methanesulphonate (Panthesine)].
    Margasiński Z; Danielak R; Rafalowska H; Nowakowska Z
    Acta Pol Pharm; 1967; 24(3):301-5. PubMed ID: 4964297
    [No Abstract]   [Full Text] [Related]  

  • 2. Separation of dihydroergotoxine (hydergine) into dihydroergocornine, dihydroergocryptine and dihydroergocristine by counter-current distribution.
    Galeffi C; Delle Monache EM
    J Chromatogr; 1974 Jan; 88(2):413-5. PubMed ID: 4205319
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of dihydroergotoxine alkaloids by gas-liquid chromatography.
    Szepesi G; Gazdag M
    J Chromatogr; 1976 Jul; 122():479-85. PubMed ID: 819452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of PH 203 (panthesine hydergine) in thrombo-embolic diseases in obstetrics and gynaecology.
    GANS B; ECKERLING B; SAX B
    S Afr Med J; 1959 Aug; 33():707-9. PubMed ID: 13826317
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombosis-prophylaxis with Panthesine-Hydergin].
    Demel H
    Munch Med Wochenschr; 1968 Oct; 110(42):2463-6. PubMed ID: 4972994
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of patent blue V in aqueous solution.
    Patel JA
    Am J Hosp Pharm; 1968 Oct; 25(10):598. PubMed ID: 5681407
    [No Abstract]   [Full Text] [Related]  

  • 7. Uncombined intermediates in FD&C Yellow No. 6.
    Marmion DM
    J Assoc Off Anal Chem; 1972 Jul; 55(4):723-6. PubMed ID: 5056219
    [No Abstract]   [Full Text] [Related]  

  • 8. [Separation of some compound drugs by the method of column chromatography. II. Separation of 1-N-methylpiperidyl-(4')-3-phenyl-4-ethylpyrazolone-(5) (piperylone) from sodium (4-methylamino-2,3-dimethyl-1-phenylpyrazolone-5) salt of methane sulfonic acid (pyralgin)].
    Danielak R; Nowakowska Z; Rafalowska H
    Acta Pol Pharm; 1968; 25(1):33-7. PubMed ID: 5697966
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies on prevention of thromboembolism using panthesin-hydergin].
    Schwalbe E; Fauner A
    Med Monatsschr; 1971 Apr; 25(4):185-8. PubMed ID: 4995458
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuropharmacological studies on hydergine.
    Depoortere H; Loew DM; Vigouret JM
    Triangle; 1975; 14(2):73-9. PubMed ID: 812222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of thrombophlebitis of the lower extremity with panthesin and hydergine (PH-203)].
    CISEK T; ARONSKI A; MASLANKA P
    Pol Tyg Lek; 1962 Apr; 17():710-3. PubMed ID: 13879603
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experiences with panthesin-hydergine (PH 203) and exacthin (ACTH) in disorders of retinal circulation].
    ORBAN T
    Ophthalmologica; 1960 Dec; 140():388-400. PubMed ID: 13731101
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of some aromatic carboxylic acids and sulphonic acids by paper chromatography and paper electrophoresis].
    Franc J; Hájková M
    J Chromatogr; 1968 Mar; 33(2):319-27. PubMed ID: 5646352
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the prophylaxis and therapy of thromboembolism. Experiences with PH 203 (panthesin plus hydergine)].
    RUBELI HH; KRULL J
    Schweiz Med Wochenschr; 1959 Oct; 89():1153-8. PubMed ID: 14439834
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversed-phase ion-pair partition chromatography of carboxylates and sulphonates.
    Wahlung KG
    J Chromatogr; 1975 Dec; 115(2):411-22. PubMed ID: 1206059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thin layer chromatography in the purity test of benzonatate].
    Brantner A; Vámos J; Végh A; Simonyi I
    Acta Pharm Hung; 1969 Sep; 39(5):232-6. PubMed ID: 5356234
    [No Abstract]   [Full Text] [Related]  

  • 17. Observations on the use of PH 203 and hydergine in some circulatory disturbances of the fundus and vascular retinopathy.
    ORMA H; VANNAS S
    Acta Ophthalmol (Copenh); 1958; 36(4):734-49. PubMed ID: 13594388
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dihydroergotoxine (Hydergine) and phenothiazines on conditioned avoidance reflexes and body temperature of the rat.
    Bálint G; Anokbonggo WW
    Acta Physiol Acad Sci Hung; 1968; 33(1):95-8. PubMed ID: 4968607
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro absorption of dihydroergotoxin methansulfonate (DHET) in simple and delayed-action form].
    Pasotti V; Fleischmann L
    Boll Chim Farm; 1975 May; 114(5):259-69. PubMed ID: 812541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analytical studies on ergot alkaloids and their derivatives. II. New systems for separation of hydrogenated ergot alkaloids by means of thin-layer chromatography].
    Reichelt J; Kudrnác S
    Cesk Farm; 1974 Feb; 23(1):13-5. PubMed ID: 4218505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.